LifeMD, Inc. — Director's Dealing 2023

Aug 1, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2022-01-27

Reporting Person: Mironov Alexander (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-27	Common Stock	A	50000	—	Acquired	74857	Direct
2023-07-28	Common Stock	A	50000	—	Acquired	124857	Direct

Footnotes

F1: The shares result from the vesting of performance-based restricted stock which vested on January 27, 2022. Each restricted stock share is equivalent to one share of the Company's common stock.

F2: The shares result from an accelerated vesting of restricted stock. Each restricted stock share is equivalent to one share of the Company's common stock.